In the published article, there was an error in the legend for Figures 1 and 2 as they have been interchanged.
The corrected legend appears below.
Figure 1
Figure 2
A correction has also been made to Abstract, Methods. This sentence previously stated:
“After five consecutive treatments with 4NQO (starting Day7), one group of mice was treated with NLGP (s.c. 25µg/mice/week)”
The corrected sentence appears below:
“After three consecutive treatments with 4NQO (starting Day7), one group of mice was treated with NLGP (s.c. 25µg/mice/week)”
The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
4NQO, CD8+ T cells, immunotherapeutics, neem leaf glycoprotein, Notch1, oral carcinogenesis, Stat3, epithelial mesenchymal transition
Citation
Das J, Bera S, Ganguly N, Guha I, Halder TG, Bhuniya A, Nandi P, Chakravarti M, Dhar S, Sarkar A, Das T, Banerjee S, Ghose S, Bose A and Baral R (2024) Corrigendum: The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study. Front. Immunol. 15:1470330. doi: 10.3389/fimmu.2024.1470330
Received
25 July 2024
Accepted
25 October 2024
Published
18 November 2024
Volume
15 - 2024
Edited and reviewed by
Alex Yee-Chen Huang, Western Reserve University, United States
Updates
Copyright
© 2024 Das, Bera, Ganguly, Guha, Halder, Bhuniya, Nandi, Chakravarti, Dhar, Sarkar, Das, Banerjee, Ghose, Bose and Baral.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Rathindranath Baral, baralrathin@hotmail.com; Anamika Bose, boseanamika@niper.ac.in
†Present address: Ipsita Guha, Division of Allergy and Immunology, Children’s Hospital of Philadelphia, Philadelphia, PA, United States; Partha Nandi, Department of Physiology, Government Degree College, Lalgarh, Jhargram, India; Tithi Ghosh Halder, Translational Genomic Research Institute, Phoenix, AZ, United States; Avishek Bhuniya, The Montaner Laboratory, The Wistar Institute, Philadelphia, PA, United States
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.